Hear CEO Mari Anne Snow describe the advantages she sees nanoparticles having over current modalities like viral vectors, LNPs, and others.

Apr 04, 2025

Posted by Eascra Biotech

How Insightec Supports Quality Clinical Trials with Medrio CDMS/EDC

Apr 04, 2025

test

Mar 28, 2025

Posted by GraVoc

From Discovery to Market: Mastering Biopharma Commercialization Milestones

Mar 25, 2025

Posted by Corval

Ubiquigent wins o2h Kickstarter Award to support its strategy of enabling the development of novel DUB-targeting compounds

Mar 25, 2025

Posted by o2h

The Top 10 Questions You Should Be Asking Your CPA This Tax Season

Mar 24, 2025

Posted by WithumSmith+Brown, PC